News

Interactions between two key structures within cells help establish the front-to-back “polarity” that is essential to cell migration, according to a new study by Weill Cornell Medicine researchers.

Scientists at Weill Cornell Medicine discovered a previously unknown link between two key pathways that regulate the immune system in mammals—a finding that impacts our understanding of chronic inflammatory bowel diseases (IBD).

Molecular and physiological changes in space travelers reveal new targets for aerospace medicine and can guide new missions, according to the results of a massive international research endeavor by investigators at Weill Cornell Medicine, SpaceX, and other organizations.

An interdisciplinary Cornell research team has developed a new surgical technique that blocks the spread of focal epileptic seizures in the brain.

By teasing out the biological mechanisms underlying postpartum mental health disorders, investigators at Weill Cornell Medicine are laying the groundwork for new ways to detect and treat women at risk. 

Home health aides (HHAs) are vulnerable to stress, isolation and depressive symptoms, which impact their own health as well as their patients’ desire to age in place, according to Weill Cornell Medicine researchers.

Dr. Javaid I. Sheikh, dean of Weill Cornell Medicine-Qatar, has been awarded the Joan and Sanford I. Weill Exemplary Achievement Award by Weill Cornell Medicine.

Awards, honors and achievements for the month of May.

Researchers find that including BRCA1 testing at the time of obstetrical prenatal carrier screening may be a cost-effective way to identify those at risk of certain cancers.

Weill Cornell Medicine scientists have uncovered the first evidence that astrocyte receptors can trigger opposite effects on cognitive function in male and female preclinical models.

Research led by Weill Cornell Medicine provides new evidence that most colorectal cancers begin with the loss of intestinal stem cells, even before cancer-causing genetic alterations appear.

On May 16, 389 expected graduates – 109 medical doctors, 46 physician assistants, 80 with doctorates and 154 with master of science degrees – in the Class of 2024 received their degrees from Weill Cornell Medicine during the institution’s annual commencement ceremony at Carnegie Hall.

Weill Cornell Medicine faculty members and alumni were honored with awards for their exemplary achievements in research, education and patient care during the institution’s commencement activities on May 15 and 16.

A team led by researchers at Weill Cornell Medicine and the Howard Hughes Medical Institute (HHMI) Janelia Research Campus has developed and tested a high-resolution sensor for tracking the real-time dynamics of ATP levels in cells and within subcellular compartments. 

Students in the Weill Cornell Graduate School of Medical Sciences' Class of 2024 were honored for their academic achievements during its convocation ceremony on May 15.

Students from the Weill Cornell Medical College Class of 2024 were recognized for their dedication to scholarship, excellence in research, devotion to teaching and service and exceptional professional qualities on May 15 during Convocation.

In a push led by Dr. Dierdre Kelleher, the Department of Anesthesiology has joined a worldwide initiative to reduce the undesirable environmental effects of anesthetic gases.

Weill Cornell Medicine-Qatar (WCM-Q) awarded Cornell University medical degrees to 50 new doctors—the largest graduating cohort to date—at the institution’s annual graduation ceremony on May 9.

Dr. Myles Wolf, an esteemed physician-scientist who specializes in nephrology, has been appointed chair of the Joan and Sanford I. Weill Department of Medicine at Weill Cornell Medicine and physician-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1.

A team led by Dr. Eddie Imada, assistant professor of research in pathology and laboratory medicine, has been awarded a three-year, $1.5 million United States Department of Defense grant for research on a cellular process called alternative polyadenylation and its role in prostate cancer.